Co-Diagnostics (LTS:0A50) Institutional Ownership : 11.60% (As of Jun. 02, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Co-Diagnostics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Co-Diagnostics's institutional ownership is 11.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Co-Diagnostics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Co-Diagnostics's Float Percentage Of Total Shares Outstanding is 97.31%.

Co-Diagnostics Institutional Ownership Historical Data

The historical data trend for Co-Diagnostics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics Institutional Ownership Chart

Co-Diagnostics Historical Data

The historical data trend for Co-Diagnostics can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	16.55	16.28	16.44	12.32	12.35	11.98	11.98	11.98	11.71	11.60

Co-Diagnostics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Co-Diagnostics (LTS:0A50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (LTS:0A50) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

CODX:USA C97:Germany

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Co-Diagnostics (LTS:0A50) Headlines

No Headlines